List of Tables
    Table 1. Anti-Obesity Prescription Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-Obesity Prescription Drugs Market Trends
    Table 3. Anti-Obesity Prescription Drugs Market Drivers
    Table 4. Anti-Obesity Prescription Drugs Market Challenges
    Table 5. Anti-Obesity Prescription Drugs Market Restraints
    Table 6. Global Anti-Obesity Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Obesity Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Obesity Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Obesity Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Obesity Prescription Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Obesity Prescription Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-Obesity Prescription Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-Obesity Prescription Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-Obesity Prescription Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Obesity Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Prescription Drugs as of 2021)
    Table 18. Top Players of Anti-Obesity Prescription Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-Obesity Prescription Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-Obesity Prescription Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-Obesity Prescription Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-Obesity Prescription Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-Obesity Prescription Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-Obesity Prescription Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-Obesity Prescription Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-Obesity Prescription Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-Obesity Prescription Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-Obesity Prescription Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-Obesity Prescription Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-Obesity Prescription Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-Obesity Prescription Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-Obesity Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-Obesity Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. F Hoffmann La Roche Ltd Corporation Information
    Table 43. F Hoffmann La Roche Ltd Description and Business Overview
    Table 44. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product
    Table 46. F Hoffmann La Roche Ltd Recent Development
    Table 47. Orexigen Therapeutics Corporation Information
    Table 48. Orexigen Therapeutics Description and Business Overview
    Table 49. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Orexigen Therapeutics Product
    Table 51. Orexigen Therapeutics Recent Development
    Table 52. Novo Nordisk A/s Corporation Information
    Table 53. Novo Nordisk A/s Description and Business Overview
    Table 54. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Novo Nordisk A/s Product
    Table 56. Novo Nordisk A/s Recent Development
    Table 57. Arena Pharmaceuticals Corporation Information
    Table 58. Arena Pharmaceuticals Description and Business Overview
    Table 59. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Arena Pharmaceuticals Product
    Table 61. Arena Pharmaceuticals Recent Development
    Table 62. Glaxosmithkline Corporation Information
    Table 63. Glaxosmithkline Description and Business Overview
    Table 64. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Glaxosmithkline Product
    Table 66. Glaxosmithkline Recent Development
    Table 67. Vivus Corporation Information
    Table 68. Vivus Description and Business Overview
    Table 69. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Vivus Product
    Table 71. Vivus Recent Development
    Table 72. Boehringer Ingelheim Corporation Information
    Table 73. Boehringer Ingelheim Description and Business Overview
    Table 74. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Boehringer Ingelheim Product
    Table 76. Boehringer Ingelheim Recent Development
    Table 77. Alizyme Corporation Information
    Table 78. Alizyme Description and Business Overview
    Table 79. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Alizyme Product
    Table 81. Alizyme Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Anti-Obesity Prescription Drugs Customers List
    Table 85. Anti-Obesity Prescription Drugs Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Obesity Prescription Drugs Product Picture
    Figure 2. Global Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Obesity Prescription Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-Obesity Prescription Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-Obesity Prescription Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-Obesity Prescription Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Anti-Obesity Prescription Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-Obesity Prescription Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-Obesity Prescription Drugs Report Years Considered
    Figure 11. Product Picture of Pediatric
    Figure 12. Product Picture of Adult
    Figure 13. Global Anti-Obesity Prescription Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Anti-Obesity Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Anti-Obesity Prescription Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Anti-Obesity Prescription Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Anti-Obesity Prescription Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Anti-Obesity Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Anti-Obesity Prescription Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Anti-Obesity Prescription Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals Pharmacies
    Figure 26. Product Picture of Retail Pharmacies
    Figure 27. Product Picture of E-commerce
    Figure 28. Global Anti-Obesity Prescription Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Anti-Obesity Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Anti-Obesity Prescription Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Anti-Obesity Prescription Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Anti-Obesity Prescription Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Anti-Obesity Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Anti-Obesity Prescription Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Anti-Obesity Prescription Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Anti-Obesity Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Anti-Obesity Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Anti-Obesity Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Anti-Obesity Prescription Drugs Value Chain
    Figure 74. Anti-Obesity Prescription Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed